Lila Hope, Partner at Cooley

Today, my guest is Lila Hope, Ph.D., a Partner at Cooley who has spent the past 20 years focused on the representation of life sciences companies discovering, developing, and marketing pharmaceutical, vaccine, medical device, diagnostic and digital health products. Lila specializes in transactions involving complex intellectual property, business, operational and legal issues, including strategic partnerships and platform discovery and option deals. In addition, she counsels clients’ management, operational and legal teams on day-to-day matters involving licensing, supply, distribution, clinical trials, research collaborations and vendor services.

She also is routinely involved in the evaluation of a company’s product rights and operational risks in connection with financing, public offering and M&A transactions. In addition to her long-established practice in the US, Lila maintains an active practice in cross-border licensing transactions, and she has concluded more than 30 transactions involving Asian biotechnology companies since 2015. Lila graduated with a JD magna cum laude from Duke University School of Law and earned her PhD in cancer biology from Stanford University School of Medicine.